Jerilyn Hansen

Educational Program Manager
@PeerView with an interest in
improving patient outcomes & think the
use of social media can only help

[PeerView @PeerView]

Don't miss our #GU22 2/18 Symposium at 6:15 PM PST: Decisions and Dilemmas in #ProstateCancer Management: Building on Progress to Advance Personalized Care Through Candid Conversations & Clinical Consults led by Drs. Dreicer, Barata (@PBarataMD), & Beer https://t.co/0HWZMfiZRu

[PeerView @PeerView]

Popular! Check out our recently released activity titled "Disparities in the Management of Inflammatory Bowel Disease" featuring Sunanda Kane, MD (@SunandaKaneMD). https://t.co/76VxuD3NjO

[PeerView @PeerView]

Discussing the potential of #BTKinhibitors in #multiplesclerosis management: Learn about this emerging therapeutic approach at our live event on February 25 at 7:00 PM EST featuring Drs. Amit Bar-Or, & Daniel S. Reich (@danielsaloreich) #actrimsforum https://t.co/qJJOH4M61N

[PeerView @PeerView]

Register for our #GU22 Thursday Symposium in-person or virtually: Achieving State-of-the-Art Care in Bladder Cancer in an Era of Innovative Therapeutic Solutions with an expert panel led by @PGrivasMDPhD, @shilpaonc and @kalasri3 https://t.co/QCUcSFevfZ #MedEd

[Rachna Shroff, MD, MS, FASCO @rachnatshroff]

This has been a transformative week for me between @theNCI Site Visit followed by #ASCO_LDP and I love this phrase and am grateful to my classmates for reminding me that “I am enough”! @ASCO @CorneliaLiedtke @cancerassassin1 @DrJNaidoo @ErikaHamilton9 @maryam_lustberg #ASCOLDP21

[PeerView @PeerView]

Curious about the latest FDA approvals of PARP inhibitors in mCRPC and their implications in #prostatecancer care? Join Robert Dreicer, MD, MS, MACP, FASCO, Pedro C. Barata, MD, MSc (@PBarataMD), and Tomasz M. Beer, MD 2/18 at 6:15 PM PST at #GU22 https://t.co/0HWZMfiZRu #MedEd

[PeerView @PeerView]

Register for our #STS2022 Live Virtual Symposium on 1/29 at 1:30 PM EST with Boris Sepesi, MD, & Tina Cascone, MD, PhD: Bringing Precision #Oncology to Early-Stage Lung Cancer With Adjuvant EGFR-Targeted Therapy https://t.co/dHjRLmt6eG #MedEd

[Stephen V Liu, MD @StephenVLiu]

Tune in for this discussion of immunotherapy and stage III NSCLC with a virtual tumor board featuring Drs. @CharuAggarwalMD @KHigginsMD and @BrendonStilesMD on Wednesday September 1 at 7pm EDT. Free CME, MOC, CC and NCPD credits available. #LCSM

https://t.co/aSYbMGP0cf

[PeerView @PeerView]

Which patients with stage III #NSCLC should/should not receive #immunotherapy, when, and how? Stephen V. Liu, MD (@StephenVLiu) will lead a lively tumor board discussion during this live web broadcast on September 1 at 7:00 PM EDT. Join us! #LCSM https://t.co/7NB4rZFBLi

[PeerView @PeerView]

Join Nicole Lamanna, MD, & Jennifer Woyach, MD, online on Thursday, September 9 at 6:15 AM CDT for a CME/MOC live web broadcast on #BTKinhibitors in #CLL https://t.co/x1YRoyl2cA #SOHO2021

[Charu Aggarwal, MD, MPH, FASCO @CharuAggarwalMD]

Wonderful multi-D panel featuring experts on management of Stage III NSCLC including cases #LCSM @BrendonStilesMD @KHigginsMD @StephenVLiu @PeerView.
Tune in! 👇🏼

[PeerView @PeerView]

Join Stephen V. Liu, MD (@StephenVLiu), Alexander Drilon, MD, D. Ross Camidge, MD, PhD, Zofia Piotrowska, MD (@ZPiotrowskaMD), & @LUNGevity online on 6/16 at 7 PM EDT for the latest updates in genomic testing & targeted treatment of #LungCancer https://t.co/OEEzcEiRjD #ASCO21

[Kadrin Wilfong, MD @KadrinWilfong]

Join @PeerView & @tigerlilycares TONIGHT, 6/10, at 7:00 PM EDT for a live web broadcast focused on disparities & treatment advances (IO, PARPi, ADCs) in #TNBC, presented by Drs. Joyce O’Shaughnessy, Rita Nanda, & Priyanka Sharma. Pre-reg: https://t.co/So8wZI3yRg #ASCO21 @Maimah

[Tigerlily Foundation @tigerlilycares]

#Immunotherapy and targeted treatment advances in #BreastCancer: Join us & @PeerView tonight for a web broadcast on June 10 at 7:00 PM EDT with Joyce O’Shaughnessy, MD, Rita Nanda, MD, & Priyanka Sharma, MD #ASCO21 #BCSM https://t.co/Ex14MCbFkr

[Jen Silverman @SpeakJen]

#Oncology professionals: Join @PeerView in June for these CME/MOC/NCPD/CPE-certified virtual web broadcasts featuring updates from #ASCO21! Register today to hear from experts in a variety of oncology topics & learn how new data are changing patient care. https://t.co/qxatuxMtW8

[Margaret Walker @MargaretWalker_]

Join @PeerView in June for CME/MOC live web broadcasts on a variety of #oncology topics. Hear updates from #ASCO21 and learn from the experts!

[PeerView @PeerView]

Join PeerView & @tigerlilycares on 6/10 at 7 PM EDT for a live web broadcast on #BreastCancer with Joyce O’Shaughnessy, MD, Rita Nanda, MD, & Priyanka Sharma, MD - Register here: https://t.co/YPZ746SP23 #ASCO21 #TNBC

[Mallory Ahern @MalloryAhern1]

Join us in June for #CME/MOC live web broadcasts on a variety of #oncology topics. Hear updates from #ASCO21 and learn from the experts! @PeerView https://t.co/pEczrdutYJ

[PeerView @PeerView]

Register now for this live web broadcast during #ASCO21 on June 4 at 7:00 PM EDT, featuring Karl D. Lewis, MD, & Ragini R. Kudchadkar, MD (@ragikudchadkar): Innovative #Immunotherapy in Advanced Basal Cell Carcinoma https://t.co/O1Etl9m1a0 #MedEd

[Margaret Walker @MargaretWalker_]

6/16 @ 7 PM EDT: Everything You Need to Know About #Biomarker Testing & Treatment of Genomically Altered #NSCLC w/ @StephenVLiu, Alexander Drilon, MD, D. Ross Camidge, MD, PhD, @ZpiotrowskaMD, & @LUNGevity - Register Now: https://t.co/8UBPuyFndk #ASCO21